mAb:

Lun Xin1, Lan Lan1, Mourad Mellal2

  • 1Product Development, Catalent Pharma Solutions, 3770 W. Jonathan Dr., Bloomington, IN 47404, United States.

Antibody therapeutics
|December 16, 2024
PubMed
概括

高通量查确定了高度单克隆抗体 (mAb) 配方的最佳条件. 这种方法平衡了辅助剂的兼容性,稳定性和粘度,用于抗体药物开发.